# A First-in-Human Single and Multiple Ascending Dose Study of MT-701

> **NCT07396909** · PHASE1 · RECRUITING · sponsor: **Mirador Therapeutics, Inc.** · enrollment: 78 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MT-701

## Key facts

- **NCT ID:** NCT07396909
- **Lead sponsor:** Mirador Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-12
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396909, "A First-in-Human Single and Multiple Ascending Dose Study of MT-701". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07396909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*